|
1
|
Ferlay J, Soerjomataram I, Ervik M,
Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and
Bray F: GLOBOCAN 2012 v1.0, cancer incidence and mortality
worldwide: IARC CancerBase No. 11 [internet]. International Agency
for Research on Cancer Lyon: http://globocan.iarc.frAccessed. December.
2013
|
|
2
|
Li S, Hu T, Lv W, Zhou H, Li X, Yang R,
Jia Y, Huang K, Chen Z, Wang S, et al: Changes in prevalence and
clinical characteristics of cervical cancer in the People's
Republic of China: A study of 10,012 cases from a nationwide
working group. Oncologist. 18:1101–1107. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shishkova N, Kuznetsova O and Berezov T:
Photodynamic therapy for gynecological diseases and breast cancer.
Cancer Biol Med. 9:9–17. 2012.PubMed/NCBI
|
|
4
|
Yu CH and Yu CC: Photodynamic therapy with
5-aminolevulinic acid (ALA) impairs tumor initiating and
chemo-resistance property in head and neck cancer-derived cancer
stem cells. PLoS One. 9:e871292014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Trushina OI, Novikova EG, Sokolov VV,
Filonenko EV, Chissov VI and Vorozhtsov GN: Photodynamic therapy of
virus-associated precancer and early stages cancer of cervix uteri.
Photodiagnosis Photodyn Ther. 5:256–259. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Choi MC, Kim MS, Lee GH, Jung SG, Park H,
Joo WD, Lee C, Lee JH, Hwang YY and Kim SJ: Photodynamic therapy
for premalignant lesions of the vulva and vagina: A long-term
follow-up study. Lasers Surg Med. Jul 14–2015.(Epub ahead of
print). View Article : Google Scholar
|
|
7
|
Saini R and Poh CF: Photodynamic therapy:
A review and its prospective role in the management of oral
potentially malignant disorders. Oral Dis. 19:440–451. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Soergel P and Hillemanns P: Photodynamic
therapy for intraepithelial neoplasia of the lower genital tract.
Photodiagnosis Photodyn Ther. 7:10–14. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dewaele M, Martinet W, Rubio N, Verfaillie
T, de Witte PA, Piette J and Agostinis P: Autophagy pathways
activated in response to PDT contribute to cell resistance against
ROS damage. J Cell Mol Med. 15:1402–1414. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Postiglione I, Chiaviello A and Palumbo G:
Enhancing photodynamyc therapy efficacy by combination therapy:
Dated, current and oncoming strategies. Cancers (Basel).
3:2597–2629. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Demyanenko SV, Uzdensky AB, Sharifulina
SA, Lapteva TO and Polyakova LP: PDT-induced epigenetic changes in
the mouse cerebral cortex: A protein microarray study. Biochim
Biophys Acta. 1840:262–270. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nicolas E, Morales V, Magnaghi-Jaulin L,
Harel-Bellan A, Richard-Foy H and Trouche D: RbAp48 belongs to the
histone deacetylase complex that associates with the retinoblastoma
protein. J Biol Chem. 275:9797–9804. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang Y, Ng HH, Erdjument-Bromage H,
Tempst P, Bird A and Reinberg D: Analysis of the NuRD subunits
reveals a histone deacetylase core complex and a connection with
DNA methylation. Genes Dev. 13:1924–1935. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kong L, Yu XP, Bai XH, Zhang WF, Zhang Y,
Zhao WM, Jia JH, Tang W, Zhou YB and Liu CJ: RbAp48 is a critical
mediator controlling the transforming activity of human
papillomavirus type 16 in cervical cancer. J Biol Chem.
282:26381–26391. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Torres-Roca JF, Eschrich S, Zhao H, Bloom
G, Sung J, McCarthy S, Cantor AB, Scuto A, Li C, Zhang S, et al:
Prediction of radiation sensitivity using a gene expression
classifier. Cancer Res. 65:7169–7176. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zheng L, Tang W, Wei F, Wang H, Liu J, Lu
Y, Cheng Y, Bai X, Yu X and Zhao W: Radiation-inducible protein
RbAp48 contributes to radiosensitivity of cervical cancer cells.
Gynecol Oncol. 130:601–608. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Soergel P, Loehr-Schulz R, Hillemanns M,
Landwehr S, Makowski L and Hillemanns P: Effects of photodynamic
therapy using topical applied hexylaminolevulinate and
methylaminolevulinate upon the integrity of cervical epithelium.
Lasers Surg Med. 42:624–630. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Choi MC, Jung SG, Park H, Lee SY, Lee C,
Hwang YY and Kim SJ: Photodynamic therapy for management of
cervical intraepithelial neoplasia II and III in young patients and
obstetric outcomes. Lasers Surg Med. 45:564–572. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ahn TG, Lee BR, Kim JK, Choi BC and Han
SJ: Successful full term pregnancy and delivery after concurrent
chemo-photodynamic therapy (CCPDT) for the uterine cervical cancer
staged 1B1 and 1B2: Preserving fertility in young women. Gynecol
Oncol Case Rep. 2:54–57. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jerjes W, Upile T, Betz CS, El Maaytah M,
Abbas S, Wright A and Hopper C: The application of photodynamic
therapy in the head and neck. Dent Update. 34:478–480, 483-484,
486. 2007.PubMed/NCBI
|
|
22
|
Hopper C: Photodynamic therapy: A clinical
reality in the treatment of cancer. Lancet Oncol. 1:212–219. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Douillard S, Rozec B, Bigot E, Aillet L
and Patrice T: Secondary reactive oxygen species production after
PDT during pulmonary tumor growth in sera of nude mice.
Photodiagnosis Photodyn Ther. 10:62–71. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gupta S, Dwarakanath BS, Muralidhar K and
Jain V: Role of apoptosis in photodynamic sensitivity of human
tumour cell lines. Indian J Exp Biol. 41:33–40. 2003.PubMed/NCBI
|
|
25
|
Ke MS, Xue LY, Feyes DK, Azizuddin K,
Baron ED, McCormick TS, Mukhtar H, Panneerselvam A, Schluchter MD,
Cooper KD, et al: Apoptosis mechanisms related to the increased
sensitivity of Jurkat T-cells vs A431 epidermoid cells to
photodynamic therapy with the phthalocyanine Pc 4. Photochem
Photobiol. 84:407–414. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ishimaru N, Arakaki R, Omotehara F, Yamada
K, Mishima K, Saito I and Hayashi Y: Novel role for RbAp48 in
tissue-specific, estrogen deficiency-dependent apoptosis in the
exocrine glands. Mol Cell Biol. 26:2924–2935. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yow CM, Wong CK, Huang Z and Ho RJ: Study
of the efficacy and mechanism of ALA-mediated photodynamic therapy
on human hepatocellular carcinoma cell. Liver Int. 27:201–208.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mikes J, Koval' J, Jendzelovský R, Sacková
V, Uhrinová I, Kello M, Kuliková L and Fedorocko P: The role of p53
in the efficiency of photodynamic therapy with hypericin and
subsequent long-term survival of colon cancer cells. Photochem
Photobiol Sci. 8:1558–1567. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Weintraub SJ, Chow KN, Luo RX, Zhang SH,
He S and Dean DC: Mechanism of active transcriptional repression by
the retinoblastoma protein. Nature. 375:812–815. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Goodrich DW: The retinoblastoma
tumor-suppressor gene, the exception that proves the rule.
Oncogene. 25:5233–5243. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nevins JR: The Rb/E2F pathway and cancer.
Hum Mol Genet. 10:699–703. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ahmad N, Gupta S and Mukhtar H:
Involvement of retinoblastoma (Rb) and E2F transcription factors
during photodynamic therapy of human epidermoid carcinoma cells
A431. Oncogene. 18:1891–1896. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Porter AG and Jänicke RU: Emerging roles
of caspase-3 in apoptosis. Cell Death Differ. 6:99–104. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Furre IE, Møller MT, Shahzidi S, Nesland
JM and Peng Q: Involvement of both caspase-dependent and
-independent pathways in apoptotic induction by
hexaminolevulinate-mediated photodynamic therapy in human lymphoma
cells. Apoptosis. 11:2031–2042. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fukuhara H, Inoue K, Kurabayashi A,
Furihata M, Fujita H, Utsumi K, Sasaki J and Shuin T: The
inhibition of ferrochelatase enhances 5-aminolevulinic acid-based
photodynamic action for prostate cancer. Photodiagnosis Photodyn
Ther. 10:399–409. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Münger K, Phelps WC, Bubb V, Howley PM and
Schlegel R: The E6 and E7 genes of the human papillomavirus type 16
together are necessary and sufficient for transformation of primary
human keratinocytes. J Virol. 63:4417–4421. 1989.PubMed/NCBI
|
|
37
|
Govan VA: Strategies for human
papillomavirus therapeutic vaccines and other therapies based on
the E6 and E7 oncogenes. Ann N Y Acad Sci. 1056:328–343. 2005.
View Article : Google Scholar : PubMed/NCBI
|
